PresentationEric SchmidtResearch Analyst Okay. Good morning once again, everyone. My name is Eric Schmidt. I'm one of the Cantor analysts. I am delighted to host our next session with Avidity Biosciences. I'm also delighted to welcome 2 of the company's senior executives. We have with us today Sarah Boyce, who's the company's President and CEO; and also Steve Hughes, the company's Chief Medical Officer. I think somewhere in the audience, Kat Lange may be here as well. She's the Chief Business Officer. There ...